prothionamide Tablets 125 mg, 250 mg

This multinational pharmaceutical company focuses on improving global health through the development and manufacturing of a wide range of affordable pharmaceuticals and nutritional products. They specialize in producing tablets, capsules, pellets, soft gelatin capsules, and oral liquids. Key therapy areas include cardiovascular diseases, diabetes, and gastrointestinal disorders. They hold prominent GMP certifications, including ISO 9001:2015 and WHO GMP accreditations for facilities in multiple regions, including the EU, North America, and Asia. Their robust R&D department drives innovation, evident in their "Dispersion Technology" for enhanced drug absorption. The company actively participates in international conferences and sponsors research initiatives focused on combating priority diseases as identified by the World Health Organization.